| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $327.09M | $291.85M | $286.83M | $247.32M | $177.08M | $175.12M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $345.32M | – | $285.57M | $251.73M | $168.32M | $184.30M |
| R&D | – | – | – | – | – | – |
| SG&A | $80.84M | $57.85M | $51.10M | $45.38M | $29.82M | $34.26M |
| Operating Income | -$11.20M | $1.91M | $1.26M | -$4.41M | $8.76M | -$9.18M |
| Interest Expense | $12.04M | $8.39M | $6.92M | $7.93M | $4.95M | $4.62M |
| Tax Expense | $1.37M | $423.00K | $729.00K | $432.00K | $1.17M | -$3.39M |
| Net Income | $77.98M | -$6.14M | -$6.82M | -$12.29M | $10.93M | -$7.28M |
| EPS (basic) | 28.8500 | -2.2300 | -2.4200 | -4.3200 | 3.7900 | -2.5300 |
| EPS (diluted) | 28.8500 | -2.2300 | -2.4200 | -4.3200 | 3.7800 | -2.5300 |
| Shares (diluted) | $2.70M | $2.75M | $2.82M | $2.85M | $2.89M | $2.88M |